Study of a chimeric foot-and-mouth disease virus DNA vaccine containing structural genes of serotype O in a genome backbone of serotype Asia 1 in guinea pigs

Acta Virologica

Volumn 54, Issue 3, 2010, Pages 189-195

  Chockalingam, A K ^a,b   Thiyagarajan, S ^a   Govindasamy, N ^a   Patnaikuni, R ^a   Garlapati, S ^a   Golla, R R ^a   Joyappa, D H ^a   Krishnamshetty, P ^c   Veluvati, V V S ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF MARYLAND   (United States)

^c ICAR NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS   (India)

Author keywords

Chimeric vaccine; DNA vaccine; Foot and mouth disease virus; Immune response

Indexed keywords

DNA VACCINE; FOOT AND MOUTH DISEASE VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FOOT AND MOUTH DISEASE VIRUS; GENETIC ENGINEERING; GENETIC TRANSFECTION; GUINEA PIG; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNIZATION; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; SEROTYPE; STRUCTURAL GENE; TECHNIQUE; VIRUS GENOME; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; CELL LINE; CLASSIFICATION; FOOT AND MOUTH DISEASE; GENETICS; HAMSTER; IMMUNOLOGY; VIROLOGY;

CAVIA; FOOT-AND-MOUTH DISEASE VIRUS; HUMAN HERPESVIRUS 5;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC ENGINEERING; GENOME, VIRAL; GUINEA PIGS; VACCINES, DNA; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 78049506789     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2010_03_189     Document Type: Article

References (30)

1. Bachrach HL (1968): Foot and mouth disease. Annu. Rev. Microbiol. 22, 201. doi:10.1146/annurev.mi.22.100168.001221
2. Berglund P, Tubulekas I, Liljestrom P (1996): Alphaviruses as vectors for gene delivery. Trends in Biotech. 14, 130-134. doi:10.1016/0167-7799(96)10019-6
3. Blanco E, Garcia-Briones M, Sanz-Parra A, Gomes P, De Oliveira E, Valero ML, Andreu D, Ley V, Sorbrino F (2001): Identification of T-cell epitopes in non-structural proteins of foot and mouth disease virus. J. Virol. 75, 3164-3174. doi:10.1128/JVI.75.7.3164-3174.2001
4. Bolwell C, Brown AL, Barnett PV, Campbell RO, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ (1989): Host cell selection of antigenic variants of foot and mouth disease virus. J. Gen. Virol. 70, 45-57. doi:10.1099/0022-1317-70-1-45
5. Brown F (1995): Antibody recognition and neutralization of foot and mouth disease virus. Semin. Virol. 6, 243-248. doi:10.1006/smvy.1995.0029
6. Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ (1998): Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 72, 4454-4457.
7. Doel TR (2003): FMD vaccines. Virus Res. 91, 81-99. doi:10.1016/S0168-1702(02)00261-7
8. Guo H, Liu Z, Sun S, Bao H, Chen Y, Liu X, Xie Q (2005): Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. Vaccine 23, 3236-3242. doi:10.1016/j.vaccine.2004.03.074
9. Lea S, Hernandez J, Blakemore W, Brocchi E, Curry S, Domingo E, Fry E, Abu-Ghazaleh R, King A, Newman J, Stuart D, Mateu MG (1994): Structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2, 123-139. doi:10.1016/S0969-2126(00)00014-9
10. Liu G, Liu Z, Xie Q, Chen Y, Bao H, Chang H, Liu X (2004): Generation of an infectious cDNA clone of an FMDV strain isolated from swine. Virus Res. 104, 157-164. doi:10.1016/j.virusres.2004.04.002
11. Mason PW, Piccone ME, McKenna TS, Chinsangaram J, Grubman MJ (1997): Evaluation of a live-attenuated foot-andmouth disease virus as a vaccine candidate. Virology 227, 96-102. doi:10.1006/viro.1996.8309
12. Mateu MG, Hernandez J, Martinez MA (1994): Antigenic heterogeneity of foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J. Virol. 68, 1407-1417.
13. Mateu MG (1995): Antibody recognition of picornaviruses and escape from neutralization, a stuctural review. Virus Res. 38, 1-24. doi:10.1016/0168-1702(95)00048-U
14. Racaniello VR, Baltimore D (1981): Cloned poliovirus cDNA is infectious in mammalian cells. Science 214, 916-919. doi:10.1126/science.6272391
15. Ravikumar P (2004): Gamma interferon adjuvant gene vaccine for immunoprophylaxis against FMD. PhD Thesis, Indian Veterinary Research Institute, Deemed University, Izatnagar, UP, India.
16. Rieder E, Baxt B, Lubroth J, Mason PW (1994): Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J. Virol. 68, 7092-7098.
17. Rieder E, Bunch T, Brown F, Mason PW (1993): Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67, 5139-5145.
18. Ruekert RR, Wimmer E (1985): Systematic nomenclature of picorna viral proteins. J. Virol. 50, 957-959.
19. Ruekert RR (1996): Picornaviridae: the viruses and their replication. In Fields BN, Knipe DM, Howley PH (Ed.): Fields Virology. 3rd ed. Lipponcott-Raven, Philadelphia, Pa, pp. 609-654.
20. Rweyemamu MM (1978): The selection of vaccine strains of foot and mouth disease. Br. Vet. J. 134, 63.
21. Salt JS (1993): The carrier state in foot and mouth disease - an immunological review. Br. Vet. J. 149, 207-223.
22. Saravanan T (2005): Construction of full length cDNA clone of foot and mouth Disease virus serotype Asia 1. PhD Thesis, Indian Veterinary Research Institute, Deemed University, Izatnagar, UP, India.
23. Suryanarayana VVS, Venkataramanan R, Rao BU, Padayatty JD (1992): Characterization and immune response of a protein produced by a cDNA clone of foot-and-mouth disease virus, type Asia 1 63/72. Biochem. Int. 26, 1003-1016.
24. Vakharia VN, Devaney MA, Moore DM, Dunn JJ, Grubman MJ (1987): Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J. Gen. Virol. 61, 3199-3207.
25. van Rensburg HG, Mason PW (2002): Construction and evaluation of a recombinant foot-and-mouth disease virus. Implications for inactivated vaccine production. Ann. N.Y. Acad. Sci. 969, 83-87.
26. van Rensburg HG, Henry TM, Mason PW (2004): Studies of genetically defined chimeras of a European type A virus and a south African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J. Gen. Virol. 85, 61-68. doi:10.1099/vir.0.19509-0
27. Ward G, Rieder E, Mason PW (1997): Plasmid DNA encoding replicating Foot-and-Mouth Disease virus genomes induces antiviral immune responses in swine. J. Virol. 71, 7442-7447.
28. Woolhouse ME, Haydon DT, Pearson A, Kitching RP (1996): Failure of vaccination to prevent outbreaks of foot and mouth disease. Epidemiol. Infect. 116, 362-371. doi:10.1017/S0950268800052699
29. Xin A, Li H, Li L, Liao D, Yang Y, Zhang N, Chen B (2009): Genome analysis and development of infectious cDNA clone of a virulence-attenuated strain of foot-and-mouth disease virus type Asia 1 from China. Vet. Microbiol. 138, 273-280. doi:10.1016/j.vetmic.2009.04.009
30. Zibert A, Maass G, Strebel K, Falk MM, Beck E (1990): Infectious foot and mouth disease virus derived from cloned fulllength cDNA. J. Virol. 64, 2467-2473.